Orange, Purple, and the Drugs Between Them

  • 5.9.2024 | 12:00 PM - 1:00 PM

Andrew Danford

WilmerHale Intellectual Property Litigation Partner Andrew Danford will participate in the Boston Bar Association’s Orange, Purple, and the Drugs Between Them webinar on Thursday, May 9, discussing hot topics related to Hatch-Waxman and biosimilar litigation, including recent scrutiny from the FTC over what patents may be listed in the Orange Book.



Not sure where to start?

Let our Knowledge Navigator direct you to content specific to where you are on your journey.

Get Started!
Rss Feed
2.21.2025
Write Warz developers on how creative writing makes a hilarious party game 
2.21.2025
Supergiant Games battles back accusations it is working around SAG-AFTRA strike 
2.21.2025
The remarkable banter of Cory Barlog and Neil Druckmann on the creative process 
Featured
blog-launch-550x370

This blog post explores certain specific terms in term sheets that will create legally binding obligations.

Schall launch feature

Partner Gary Schall shares some practical advice about term sheets: Don’t attempt any transaction without one.

2.20.2025
Corporate Transparency Act: Judge Clears Way for CTA; Reporting Requirements Back in Effect
2.12.2025
Corporate Transparency Act: It’s Still Paused (For Now)
12.27.2024
Corporate Transparency Act: Preliminary Injunctive Relief Reinstated by Fifth Circuit (For Now)